spacer
home > ict > spring 2018 > revolution or evolution?
PUBLICATIONS
International Clinical Trials

Revolution or Evolution?

The pharmaceutical industry is abuzz with visions of cloudenabled services and new technologies that foretell a digital transformation of the clinical trial process. Recent industry conferences have focused on the ‘virtualisation’ of trials, forecasting patient-direct, ‘visit-/site-less’ approaches underpinned by strides in artificial intelligence (AI). In this worldview, a new generation of healthcare-grade wearable devices will feed a shareable, platform-agnostic ‘Big Data’ machine that revolutionises the world of drug development – or so many pundits say.

The vision of the future and the promise of speed and efficiency for drug development is exciting and aweinspiring. However, the reality of Big Data, automation, and AI accelerating drug discovery will – and should – come as an evolution in clinical trials, not a revolution.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
David Goldston is Managing Director at Veracity Logic – an IRT company based in North Carolina that deployed IRT systems for clinical trials in more than 50 countries over the past decade. He has more than 25 years of experience in the healthcare and clinical research industries, including clinical data management for Quintiles and PPD. David also served as Computer Systems Administrator for the office of information systems at the University of North Carolina at Chapel Hill School of Medicine, US. He earned a master’s degree in information science at the University of North Carolina at Chapel Hill, US.
spacer
David Goldston
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Mr Turhan Ozen Chief Cargo Officer at Turkish Airlines elected to the International Air Cargo Association (TIACA) Committee

Turhan Ozen, serving as Chief Cargo Officer at the global brand Turkish Airlines, was elected to the International Air Cargo Association (TIACA) Committee, the joint voice of the industry that aims to enhance the air cargo profile with intensive efforts towards the global standards.
More info >>

White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement